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Neurotropic herpesviruses exit the peripheral nervous system and return to exposed body surfaces
following reactivation from latency. The pUS9 protein is a critical viral effector of the anterograde axonal
transport that underlies this process. We recently reported that while pUS9 increases the frequency of
sorting of newly assembled pseudorabies virus particles to axons from the neural soma during egress,
subsequent axonal transport of individual virus particles occurs with wild-type kinetics in the absence of
the protein. Here, we examine the role of a related pseudorabies virus protein, pUL56, during neuronal
infection. The ﬁndings indicate that pUL56 is a virulence factor that supports virus dissemination in vivo,
yet along with pUS9, is dispensable for axonal transport.
& 2015 Elsevier Inc. All rights reserved.Introduction
The herpesviridae are a diverse family of viruses that share a
core set of conserved properties (Davison et al., 2009; McGeoch
et al., 2006). Their common morphology consists of a double-
stranded linear DNA genome housed in an T¼16 icosahedral
capsid, surrounded by a proteinaceous tegument layer and mem-
brane envelope (Pellet et al., 2007). Infections by these viruses
alternate between productive and latent states, although tissue
tropism and the site of latency vary across herpesviridae sub-
families and genera. For members of the simplexvirus and var-
icellovirus genera of the alphaherpesvirinae subfamily, latency
occurs in ganglia of the peripheral nervous system (PNS). Periodic
reactivation from the latent state results in nascent particle
assembly and subsequent transmission back to body surfaces,
where virus shedding can be accompanied by mucosal or skin
lesions. In rare events, infections can result in life-threatening
encephalitic disease.
The transmission of viral particles outward from sensory
ganglia following a reactivation event is termed anterograde
axonal transport, which occurs following the induction of viral
gene expression and virion assembly in neurons. Newly assembled
virus particles are sorted within the cytoplasm of the neuron from-Immunology, Morton Bldg.,
f Medicine, Chicago, IL 60611,
. Smith).the soma to the axon, and are then transported along microtubules
to the distal axon terminals where the virus spreads to the
innervated tissue (Miranda-Saksena et al., 2000; Smith et al.,
2001). Studies of pseudorabies virus (PRV; a highly neurovirulent
varicellovirus that infects a broad range of veterinary hosts, and
serves as a model for encephalitic disease) and herpes sim-
plexvirus type 1 (HSV-1; a rarely neurovirulent simplexvirus that
causes herpes labialis in humans) indicate that fully assembled
virus particles are transported anterogradely in host vesicles
(Antinone and Smith, 2006; Antinone et al., 2010; Ch'ng and
Enquist, 2005; Cook and Stevens, 1973; Feierbach et al., 2007; del
Rio et al., 2005; Field and Hill, 1974; Hill et al., 1972; Kristensson
et al., 1974; LaVail et al., 1997; Lycke et al., 1988; Lyman et al., 2007;
Maresch et al., 2010; Negatsch et al., 2010; Huang et al., 2011;
Wisner et al., 2011). A viral type-II transmembrane protein that is
resident in the transport vesicle membrane, pUS9, serves as an
effector of anterograde axonal transport for PRV and HSV-1 by
augmenting the cytoplasmic sorting of viral particles into axons
from the neuronal cell body (Ch'ng and Enquist, 2005; Brideau
et al., 1998; Snyder et al., 2008; Howard et al., 2013; LaVail et al.,
2007; Kratchmarov et al., 2015). Following sorting, pUS9 remains
associated with viral particles (Taylor et al., 2012), but is never-
theless dispensable for the subsequent microtubule-based ante-
rograde transport that occurs within axons (Daniel et al., 2015).
The magnitude of the anterograde-deﬁcit displayed by recom-
binant viruses lacking pUS9 depends on the infection model. PRV
does not reach visual centers of the brain by anterograde transport
from the rat retina in the absence of pUS9 (Daniel et al., 2015;
G.R. Daniel et al. / Virology 488 (2016) 179–186180Brideau et al., 2000), whereas HSV-1 lacking pUS9 spreads in the
same circuit within a mouse host, but at reduced levels (McGraw
et al., 2009). Yet the PRV deﬁcit is also not absolute, as PRV lacking
pUS9 spreads anterogradely between nuclei within the brain
(Brideau et al., 2000; Card et al., 1998). These ﬁndings suggest that
additional viral proteins promote transport independently of
pUS9. In this report, we examined the contribution of pUL56,
which like pUS9 is a type-II transmembrane protein that is pro-
posed as a candidate transport effector (Koshizuka et al., 2002,
2005; Rosen-Wolff et al., 1991). PRV strains lacking pUS9, pUL56,
or both proteins were examined in cultures of primary sensory
neurons and in animals. Our ﬁndings indicate that in PRV, pUL56
contributes to spread and virulence in animals, but unlike pUS9,
does not contribute to axonal sorting. Furthermore, pUL56 and
pUS9 provide no measurable contribution to the process of
microtubule-based anterograde transport post-sorting in axons.Results
Initial characterization of mutant viruses
To assess the contribution of pUL56 toward neuronal infection,
PRV deleted for the UL56 gene was derived from a pBecker3
infectious clone encoding a pUL25/mCherry ﬂuorescent capsid tag.Fig. 1. Deletion of UL56 or US9 from PRV does not impair replication in the PK15 epithe
infection with the parent PRV strain or derivatives lacking UL56 or US9, singly or in
experiments were repeated in triplicate (error bars indicate standard deviation). (B) Tite
standard error of the mean). (C) Single-step replication kinetics of parental, ΔUL56, or
natants at the indicated times, followed by plaque assay to determine titer.The capsid tag allows for imaging of individual viral particles in
living cells (Smith and Enquist, 2000; Bohannon et al., 2012; Tischer
et al., 2006). The deletion removed the entire UL56 coding sequence
and further encompassed an extended sequence referred to as ORF
1.2: a putative coding region that is in-frame and co-terminal with
UL56 (Klupp et al., 2004). The resulting deletion virus, PRV-GS4673,
is referred to as the ΔUL56 virus in this report (Table 1). The ΔUS9
mutant, PRV-GS5469, has the second codon through the last in-
frame ATG replaced with a stop codon, and was previously descri-
bed (Daniel et al., 2015). The ΔUL56 and ΔUS9 viruses remained
fully competent to spread in PK15 epithelial cells (Fig. 1A) and
propagated to titers equivalent to the parental strain (Fig. 1B) with
normal kinetics (Fig. 1C). Consistent with prior reports, these ﬁnd-
ings document that neither pUS9 nor pUL56 signiﬁcantly contribute
to productive infection in non-neuronal cell culture (Brideau et al.,
2000; Baumeister et al., 1995), and further indicate the UL56 dele-
tion did not result in polar effects on the downstream antisense
transcripts for UL52 (helicase/primase), UL53 (gK) and UL54
(ICP27), which share a poly-adenylation signal that is 145 nt
downstream of the UL56 deletion (Schwartz et al., 2006).
Retrograde axonal transport in culture
Membrane proteins are not expected to contribute to the initial
seeding of neurons by retrograde axonal transport, as this processlial cell line. Plaque diameters (A) and titers (B) were measured on PK15 cells after
combination. (A) Greater than 40 plaques were measured per experiment and
r measurements were compiled from three or more viral stocks (error bars indicate
ΔUS9 infection was determined by collecting infected cells or infected cell super-
Fig. 2. Deletion of UL56 from PRV does not alter retrograde or anterograde transport dynamics of viral particles in culture. Primary sensory neurons were infected with the
parental strain or ΔUL56 PRV and pUL25/mCherry capsids were imaged during ingress from 15 to 60 min postinfection (upper panels) and during egress from 10 to 13 hpi
(lower panels). Viral particles moving in axons greater than 0.5 mm were tracked and individual velocities and run lengths were measured during ingress (parent, n¼288;
ΔUL56, n¼175) and egress (parent, n¼38; ΔUL56, n¼48). Gaussian (velocities) or decaying exponential (run lengths) curves were ﬁt to histograms by non-linear regression;
for all experiments, curve-ﬁtting produced R2 values40.96. Insets show average velocity (left panels) and run length (middle panels); error bars indicate standard error of
the mean. The frequency of capsid axonal transport events (ﬂux) was measured as the number of capsids moving per axon over a 30 s period during ingress (parent, n¼99;
ΔUL56, n¼70) and egress (parent, n¼21; ΔUL56, n¼37) (right panels); error bars indicate standard deviation.
G.R. Daniel et al. / Virology 488 (2016) 179–186 181occurs after the virion envelope is removed following fusion-based
entry into axons (Nicola et al., 2005). Nevertheless, retrograde
axonal trafﬁcking was monitored to conﬁrm that deletion of UL56
did not impair this early stage of neuronal infection (Smith et al.,
2004). Dorsal root ganglia (DRG) explants of sensory neurons were
infected with either the parental ﬂuorescent PRV strain or its
ΔUL56 derivative (these experiments were conducted con-
currently with the previously described ΔUS9 mutant (Daniel
et al., 2015)). The motion of incoming ﬂuorescent capsids was
tracked during the ﬁrst hour post-infection to determine velocities
and run lengths of individual viral particles, and the frequency of
transport events (ﬂux). Based on this analysis, deletion of UL56 did
not perturb retrograde transport of viral particles (Fig. 2, upper
panels).
Anterograde axonal transport in culture
Following replication, newly-assembled PRV particles trafﬁc
from the soma of the neuron to the axon. To obtain an accounting
of viral particle sorting into axons, disassociated DRG sensory
neurons were plated sparsely to limit axon interactions, and
infected two days post-culturing. The number of virus particles
along the length of the axon in an infected neuron, including the
terminal, was enumerated at both 3 hpi (prior to the onset of
anterograde axonal transport) and from 15 to 18 hpi (Smith et al.,
2001; Antinone et al., 2010). Unlike the sorting defect exhibited by
the ΔUS9 mutant, the ΔUL56 virus produced particles that sorted
into axons as efﬁciently as the parental strain (Fig. 3A). Further-
more, the ΔUL56 particles accumulated at the terminals of theaxons by 15–18 hpi, providing an initial indication that micro-
tubule transport within axons occurred normally (Fig. 3B,C).
To examine the intra-axonal transport phenotype of the ΔUL56
virus more closely, individual virus particles moving in axons were
recorded by time-lapse imaging and the kinetics of transport were
measured. The ΔUL56 mutants transported in the anterograde
direction in axons like the parental strain in terms of velocity, run
length, and ﬂux (Fig. 2, lower panels). A similar result was
observed in experiments conducted in parallel with the ΔUS9
mutant (Daniel et al., 2015). Because pUS9 and pUL56 are both
type-II structural membrane proteins (Brideau et al., 1998; Kosh-
izuka et al., 2002), a ΔUL56/ΔUS9 double-mutant virus encoding
the pUL25/mCherry capsid tag (PRV-GS5658) was made to deter-
mine if the proteins possessed redundant function (Table 1). The
ΔUL56/ΔUS9 virus produced plaque sizes and titers on PK15 epi-
thelial cells equivalent to the individual mutants and the parental
strain (Fig. 1A,B). Like the ΔUS9 and ΔUL56 viruses, the ΔUL56/
ΔUS9 recombinant remained competent for anterograde axonal
transport, indicating that the engagement of kinesin motors that
move PRV anterograde in axons can occur by a mechanism that is
independent of these type-II membrane proteins (Supplementary
movie).
Virulence and dissemination in the nervous system
CD-1 mice were infected intranasally with the parental or
mutant PRV strains encoding the pUL25/mCherry fusion, and the
mean survival times were determined (Klopﬂeisch et al., 2004).
Infection with the parental PRV resulted in a mean survival time of
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Fig. 3. Deletion of US9, but not UL56, results in diminished accumulation of viral
particles at axon terminals late in infection. (A) Sparsely seeded dissociated pri-
mary sensory neurons were infected with parental, ΔUL56, or ΔUS9 PRV, and the
number of ﬂuorescent capsids localized along the length of individual axons were
counted at 3 hpi and 15–18 hpi. Only infected neurons extending axons4100 mm
that could be traced for their entire length were included in the analysis. Error bars
indicate standard deviation. Signiﬁcance was determined with one-way ANOVA
and Tukey’s post-test. (B) Primary sensory neurons were infected with parental,
ΔUL56, ΔUS9, or ΔUL56/ΔUS9 virus and the distal ends of the neurons were
imaged between 15 and 18 hpi. (C) The abundance of viral particles at axon
terminals is reported as a frequency based on the number of capsids observed per
terminal (parent, n¼213; ΔUL56, n¼45; ΔUS9, n¼109; ΔUL56/ΔUS9, n¼236).
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Fig. 4. Contributions of pUS9 and pUL56 to PRV virulence. Five CD-1 mice were
infected by intranasal instillation with each virus, and mean survival times were
determined. A one-way ANOVA with Tukey post-test was used to determine
signiﬁcance.
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Fig. 5. pUL56 is dispensable for anterograde spread of PRV in rat visual circuits.
Long Evans rats were infected by intravitreal injection with parental, ΔUL56, or
ΔUS9 PRV. The location of the injection in the eye is indicated by an asterisk (*). At
48 hpi, the animals were sacriﬁced. Peripheral tissue sections of the eye, including
retinal ganglion cells (RGC), or brain sections of retinorecipient visual centers,
including the lateral geniculate nucleus (LGN) and superior colliculus (SC), were
examined for infected neurons, indicated by red-ﬂuorescence emissions from the
pUL25/mCherry capsid fusion. For each infection, three animals were examined. A
(þ) indicates the presence of red-ﬂuorescent/infected cells.
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Infection with the ΔUL56, ΔUS9, or ΔUL56/ΔUS9 virus extended
mean survival times signiﬁcantly, indicating that both pUL56 and
pUS9 are required for full virulence in this model (Fig. 4).
To determine the degree to which the parental and mutant
viruses could infect circuits via anterograde axonal transport,
Long-Evans rats were infected in the vitreous humor of the eye to
initiate an infection in the retinal ganglion neurons that project
axons to the visual centers of the brain. This is the model tradi-
tionally used to discern transneuronal anterograde transmission
defects of PRV in the mammalian nervous system, a model for
which PRV requires pUS9 (LaVail et al., 2007; Daniel et al., 2015;Brideau et al., 2000; Pickard et al., 2002; Dingwell et al., 1995;
Husak et al., 2000; Card et al., 1991). At 48 hpi, the animals were
sacriﬁced, and tissue sections from the eye or the retinorecipient
visual centers of the brain were prepared. Infected cells were
identiﬁed based on the presence of intranuclear ﬂuorescence from
newly assembled capsids containing the pUL25/mCherry tag. The
transmission of the ΔUL56 virus to visual centers was equivalent
to the parental strain, indicating that pUL56 is not required for
transneuronal spread following anterograde axonal transport in
the mammalian nervous system (Fig. 5). This result extends the
anterograde trafﬁcking results obtained in cultured sensory neu-
rons (Figs. 2 and 3), but does not account for the virulence defect
of the ΔUL56 mutant observed in mice (Fig. 4). Therefore, we next
G.R. Daniel et al. / Virology 488 (2016) 179–186 183examined the neuroinvasive property of the ΔUL56 mutant in a
retrograde circuit.
Long-Evans rats were infected by injecting either the parental,
ΔUL56, ΔUS9, or the ΔUL56/ΔUS9 virus into the anterior chamber
of the eye. In this model, viral replication initially occurs in the iris
and ciliary body, which precedes entry into axons innervating
these tissues and retrograde axonal transport to peripheral gang-
lia, including the superior cervical ganglion (SCG) (Zaichick et al.,
2013). The rat SCG contains ﬃ30,000 neurons, of which 600–1000
project directly to the eye (Strack and Loewy, 1990). At the indi-
cated times, animals were sacriﬁced, transcardially perfused, and
the SCG ipsilateral to the injected eye was removed and prepared
for microscopic examination. Infection with the parental virus
resulted in labeling of 45000 neurons in the SCG, indicating
infection had surpassed the initial seeding of the ganglion. In
contrast, although the ΔUS9 and ΔUL56/ΔUS9 viruses seeded the
SCG, the number of infected neurons did not surpass the number
of neurons that project to the eye, consistent with these infections
being restricted to neurons that innervated the eye directly. This
may be explained by the reduced capacity of the ΔUS9 viruses to
engage in anterograde axonal transport, which should effectively
imprison the virus in the initially seeded SCG neurons. Although
the ΔUL56 mutant did not share the ΔUS9 sorting defect, it pre-
sented an intermediate defect in the number of neurons infected
in the SCG, indicating that pUL56 enhances infection of the per-
ipheral nervous system (Fig. 6).Discussion
To transmit between hosts, a latent neuroinvasive herpesvirus
infection must reactivate and send newly-assembled viral particles
from peripheral sensory ganglia to body surfaces by anterograde
axonal transport. The same process can, in rare instances, result in
transmission of infection from sensory neurons to the central
nervous system (CNS), resulting in life-threatening encephalitic
disease (Smith, 2012). Because reactivation from latency is nor-
mally sporadic and of varying magnitude, anterograde axonal
transport is typically studied in models of acute infection. Thus, in
a CNS invasive model of infection based on inoculating PRV in the
vitreous chamber of the rat eye, virus infects local neurons in the
retina (retinal ganglion cells) and then transmits within theseFig. 6. pUL56 promotes infection of the superior cervical ganglion. Parental, ΔUL56, ΔUS
the eye of male Long Evans rats. The location of the injection in the eye is indicated by an
ganglion (SCG) was removed, sectioned, and scored for infected neurons based on red-ﬂu
the time of imminent death from infection. The lower dashed line indicates the number o
the total number of neurons, ﬃ30,000, that comprise the SCG.neurons to the brain by anterograde axonal transport. For PRV, the
pUS9 type-II membrane protein is often referred to as an essential
determinant for anterograde axonal transmission because ΔUS9
mutants of PRV fail to spread to the brain in this rat eye model
(Brideau et al., 2000). However, pUS9 is not essential in all con-
texts. For example, in an intracranial model of CNS infection, pUS9
is dispensable for anterograde axonal transport between distal
nuclei within the brain (Brideau et al., 2000).
Anterograde axonal transport consists of two steps. First, nas-
cent cytoplasmic viral particles are sorted from the cell body into
the axon. Once in the axon, the particles transport to the terminal
by plus-end directed microtubule transport. The latter is sustained
over distances of several centimeters to nearly a meter (Tannous
and Grose, 2011). In the absence of pUS9, the initial step of PRV
sorting into axons occurs infrequently (Taylor et al., 2012); how-
ever, the few PRV particles that transport in the absence of pUS9
do so with kinetics that are indistinguishable from PRV encoding
pUS9 (Daniel et al., 2015). Because ΔUS9 PRV can sustain long-
distance transport within axons to spread anterogradely in the
intracranial model and in cultured primary neurons, this indicates
that additional effectors of axonal transport may exist (Ch'ng and
Enquist, 2005; Daniel et al., 2015; Brideau et al., 2000).
A second type-II transmembrane protein, pUL56, was sug-
gested to have transport effector functions based on studies of
HSV-2 (Koshizuka et al., 2002, 2005, 2006). Although pUL56 was
described initially in HSV, phylogenetic studies have identiﬁed a
UL56 ortholog in PRV, previously called ORF-1 (Davison, 2010). We
chose to delete ORF-1/UL56 along with the an overlapping and co-
terminal coding sequence called ORF1.2, to effectively rule out
either as encoding effectors of axonal transport. Deletion of UL56
and ORF1.2 from PRV did not impair viral replication in epithelial
cells, in agreement with previous reports (Baumeister et al., 1995).
The retrograde axonal transport kinetics of the mutant were
equivalent to the parental strain following entry into primary
cultured neurons and the kinetics were also unperturbed for
anterograde transport during neuronal egress, with the latter
culminating in normal accumulation of PRV particles at axon
terminals. These ﬁndings were consistent with the subsequent
studies in animals, where the mutant was not impaired for
infection of visual centers of the rat brain via anterograde trans-
port from the eye. We conclude that pUL56 (and products from
ORF1.2) is not an effector of PRV anterograde transport in primary9, or a ΔUL56/ΔUS9 double-mutant virus was injected into the anterior chamber of
asterisk (*). Animals were sacriﬁced at the indicated times and the superior cervical
orescence emissions from the pUL25/mCherry capsid fusion. The symbol ‘†’ denotes
f neurons in the SCG that project directly to the eye. The upper dashed line indicates
Table 1
Viruses used in this study.
Virus Reporter tag Mutation Moniker Source
PRV-GS4284 pUL25/
mCherry
 Parent Bohannon et al.
(2012)
PRV-GS4673 pUL25/
mCherry
ΔUL56
ΔORF1.2
ΔUL56 This study
PRV-GS5469 pUL25/
mCherry
ΔUS9 ΔUS9 Daniel et al.
(2015)
PRV-GS5658 pUL25/
mCherry
ΔUL56
ΔORF1.2 ΔUS9
ΔUL56/ΔUS9 This study
G.R. Daniel et al. / Virology 488 (2016) 179–186184cultured neurons or in vivo. Unlike pUS9, pUL56 did not promote
initial sorting of cytoplasmic PRV particles into axons, and neither
pUS9 nor pUL56 (deleted individually or together) were required
for intra-axonal transport of particles beyond the sorting barrier.
Whether other viral effectors of kinesin-based anterograde
trafﬁcking encoded by PRV contribute to post-sorting anterograde
axonal transport remains an open question. Because PRV trans-
ports anterogradely as a fully-assembled virus particle within the
lumen of a transport vesicle, there may be no need for a virally-
encoded transport effector during this stage of infection if the
vesicle is targeted to the axon terminal by the cell. However, there
are reports that in addition to vesicle-based anterograde transport,
HSV-1 may uniquely be able to transport as a proteinaceous cap-
sid/tegument particle directly in the cytosol of the axon (Miranda-
Saksena et al., 2000; Wisner et al., 2011). In this scenario, HSV-1
would require a direct effector of kinesin recruitment. In either
scenario, the pUL36 large tegument protein is an interesting can-
didate effector based on its role in kinesin-based transport of
capsids in vitro (Shanda and Wilson, 2008).
Whereas deletion of UL56 had no impact on anterograde
transport in vivo, infection of peripheral ganglia, a retrograde
circuit, was attenuated. This reduction in infection was not
accounted for in the culture studies where defects in propagation,
spread, and axonal transport were not observed. Nevertheless, the
defect corresponded to reduced virulence; in fact, in the mouse
intranasal model, ΔUL56 infection was more attenuated than
infection by the ΔUS9 virus. pUL56 has multiple reported func-
tions in related alphaherpesviruses, including modulation of cell-
surface markers, regulation of cellular ubiquitin ligases, and
interaction with viral proteins that ultimately interact with gly-
coprotein E (Koshizuka et al., 2006; Ushijima et al., 2010, 2009,
2008; Said et al., 2012; Han et al., 2011; Huang et al., 2014, 2015;
Claessen et al., 2015; Soboll Hussey et al., 2014). These interactions
could promote innate immune evasion in the host. Further studies
will be needed to identify the mechanism by which pUL56, and
possibly products of ORF1.2, contributes to virulence.Materials and methods
Plasmid construction
Recombinant PRV strains used in this study were constructed
with two-step RED-mediated recombination using a pBecker3
infectious clone, GS4284, previously made to express a pUL25/
mCherry capsid fusion (Smith and Enquist, 2000; Bohannon et al.,
2012; Tischer et al., 2010). To delete the UL56/ORF1.2 locus, the
following primer pair was made with 5’ homologies ﬂanking the
ORF1.2 coding sequence to be deleted and 3' homologies (under-
lined) to pEPkan-S2 (Tischer et al., 2006): 5' CGCAGGTCCT-
GCGGGCGTACCAGATCGGTTGATGTGCGAACGATGT GACCAATAAAC-
TCGAGGATGACGACGATAAGTAGGG and 5' GAGACGCGGATATCGA-
TAGGACTGGCGAGCCGAGTTTATTGGTCAC ATCGTTCGCACATCCAA-
CCAATTAACCAATTCTGATTAG. The PCR product was recombined
into infectious clone GS4284 and GS5469, the latter of which is a
derivative of GS4284 deleted for the US9 gene (Daniel et al., 2015).
Two-step recombination resulted in infectious clones GS4673 and
GS5658 (Table 1). The deletion of ORF1.2 removed all codons fol-
lowing the start ATG, and preserved the stop codon and 3'
untranslated region. This deletion also removed the smaller UL56
coding sequence, which is embedded in and co-terminal with
ORF1.2. The deletion was separated from the polyadenylation
sequence of the downstream UL54 antisense transcript by 145 nt.
Mutant viruses were initially identiﬁed by restriction enzyme
analysis and conﬁrmed by sequencing.Cells and viruses
PK15 cells were maintained in 10% bovine growth supplement
(BGS; HyClone). During infection, the BGS concentration was
reduced to 2%. Infectious clones were transfected into PK15 cells as
previously described to produce stocks of recombinant PRV
(Luxton et al., 2005). Working stocks were made by an additional
passage through PK15 cells. Virus stocks were titered on PK15 cells
as previously described (Smith and Enquist, 1999). Titer mea-
surements were compiled fromZ3 individual working stocks. The
diameters of greater than 40 plaques on PK15 cells were measured
for each virus based on red capsid ﬂuorescence emissions, and this
was then repeated a total of three times for each virus. Final
measurements were normalized as a percent of the parental virus
plaque diameter. Single-step growth kinetics were determined as
previously described (Tirabassi and Enquist, 1998).
Neuronal culture
Sensory neurons were isolated from the dorsal root ganglion
(DRG) of embryonic (E8-E10) chicks and cultured as previously
described as either whole explants or disassociated cells (Smith
et al., 2001, 2004). DRG neurons were cultured onto 22 mm2 No.
1.5 glass coverslips treated with poly-DL-ornithine (PO). Laminin
was added as a second substrate for whole explant cultures.
Neuron cultures were maintained for 2–3 days with partial media
change on day 2, and then infected with recombinant PRV isolates.
Infections were conducted in a 2 ml volume in a well of a 6-well
tissue culture tray (one coverslip per well). Explants were infected
with 7–8107 PFU/ml and imaged during the ﬁrst hour post-
infection. This provided large numbers of retrograde transport
events for analysis. In contrast, dissociated neurons were infected
with 2–3106 PFU/ml and imaged for egress (anterograde trans-
port) events from 10 to 13 hpi as previously described (Antinone
et al., 2010). While this protocol limited the number of egress
events that were captured, the low density of plated neurons
allowed for unambiguous assessment of transport direction
(anterograde vs. retrograde), which is necessary during late time
points when egress from primary infected neurons can be con-
founded by retrograde transport events following entry into a
second round of cells.
Fluorescence microscopy and image analysis
Virus particles were tracked in axons as described previously
(Zaichick et al., 2013). For virus transport experiments in dis-
sociated or explant DRGs, imaging was done on a Nikon Eclipse
TE2000-U wide-ﬁeld ﬂuorescence microscope with a 1001.49
numerical aperture (NA) objective and a Cascade II:512 camera.
Emissions from mCherry were acquired using 100-ms streaming
exposures. The velocities and run lengths of virus particles moving
greater than 0.5 mm were measured with the Kymograph function
in the MetaMorph software package. The ΔUL56 transport data
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and ΔUS9 transport analysis that was previously published and
included here for direct comparison (Daniel et al., 2015). Mea-
surement of particle ﬂux was performed by counting the number
of capsids that passed through a deﬁned position along the axon
that was demarcated by a 5 mm perpendicular reference line,
during a 30 s period.
Viral particle accumulation in axons were imaged by virtue of
the mCherry-capsid reporter fusion using 1 s exposures on an
inverted wide-ﬁeld Nikon Eclipse TE2000-E ﬂuorescence micro-
scope ﬁtted with a 601.4 NA objective and a Photometrics
CoolSnap HQ2 camera. Experiments were repeated in triplicate.
Viral particle accumulation along the length of axons was enum-
erated in axons whose lengths were greater than 100 mm and were
as long as 450 mm; axons shorter than one ﬁeld of view (100 mm)
were excluded from the count. All counts were determined
manually. In regions with dense capsid accumulation, counts were
likely underestimates since images were taken in a single focal
plane and capsids coincident with each other were only scored as
a single particle. At least 6 neurons per sample were counted for
the 3 hpi time point, and Z20 neurons per sample were counted
in total for the 15–18 hpi time point across 2 experiments. Fluor-
escent plaque diameters were measured with a 10 objective and
100 ms exposures.
Animal studies
The use of animals in this study was approved by the University
of Nebraska-Lincoln Institutional Animal Care and Use Committee.
CD-1 mouse infection: Male mice (received from Charles River at
6 weeks of age) were acclimated to a 12:12 light:dark cycle for at
least 2 weeks prior to infection. When 8–15 weeks old, animals
were infected intranasally with 8–9105 PFU/nostril (in a 5 ml
volume/nostril) of PRV under 2.5% isoﬂuorane inhalation anes-
thesia, as previously described (Bohannon et al., 2012). Five ani-
mals were monitored per virus to determine mean time of death
(MTD). A one-way ANOVA with Tukey post-test were used to
determine signiﬁcance. Long-Evans rat infection: male rats
(received from Charles River at 8 weeks of age) were acclimated to
a 12:12 light:dark cycle for at least 2 weeks prior to infection.
When 10–16 weeks old, animals were infected with PRV under
2.5% isoﬂuorane inhalation anesthesia by unilaterally injecting
either 10 ml of aﬃ1108 PFU/ml stock into the vitreous humor of
the eye or 2 ml of the same stock into the anterior chamber of the
eye, as previously described (Lee et al., 2009). Animals were
sacriﬁced at the indicated times by transcardial perfusion with
0.9% saline followed by 4% paraformaldehyde in 0.1 M phosphate
buffer (PB). The brain and the superior cervical ganglion (SCG)
ipsilateral to the injected eye were removed, post-ﬁxed overnight
at 4 °C in 4% paraformaldehyde in PB with 20% sucrose. Tissue was
sectioned at 30 mm on a Leica cryostat, mounted on slides, cover-
slipped with Vectashield and examined using a Leica DM5500 B
ﬂuorescence microscope ﬁtted with a Hamamatsu CCD ORCA-ﬂash
4.0 digital camera.Acknowledgments
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